Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An exploratory Phase 1b, randomized, double-blind, placebo-controlled, crossover, multi-center study PIPE-791 for the treatment of chronic pain associated with osteoarthritis (OA) and low back pain (LBP)

Next Previous
X
Search
Trial Profile

An exploratory Phase 1b, randomized, double-blind, placebo-controlled, crossover, multi-center study PIPE-791 for the treatment of chronic pain associated with osteoarthritis (OA) and low back pain (LBP)

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 25 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PIPE 791 (Primary)
  • Indications Pain
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 25 Nov 2024 New trial record
    • 18 Nov 2024 According to Contineum Therapeutics media release, the study is expected to begin in the first quarter of 2025. The Company expects to enroll approximately 40 patients at up to five sites, and a treatment duration of 28 days. Contineum anticipates topline data from the PIPE-791 Phase 1b chronic pain study in early 2026.
    • 18 Nov 2024 According to Contineum Therapeutics media release, company announced authorization of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) for PIPE-791 for the treatment of chronic pain associated with two separate indications, osteoarthritis (OA) and low back pain (LBP)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top